Wellbutrin XL tablets, 150mg, marketed by GlaxoSmithKline, had US sales of approximately $930 million for the 12 months ended March 2008, according to IMS data.
Wellbutrin XL tablets, 150mg, marketed by GlaxoSmithKline, had US sales of approximately $930 million for the 12 months ended March 2008, according to IMS data.